GSK image

GSK licences RA drug

June 5, 2013
Research and Development, Sales and Marketing GSK, RA, morphosys

GlaxoSmithKline is gambling millions of euros on an investigational drug in a bid to get an edge in the fight …

astrazeneca image

AstraZeneca abandons late-stage RA drug

June 5, 2013
Research and Development, Sales and Marketing AstraZeneca, RA, Rigel

AstraZeneca is to exit development of a new rheumatoid arthritis drug, after Phase III trials produced disappointing results.The Anglo-Swedish firm …

astrazeneca image

AstraZeneca/BMS drug granted speedy FDA review

June 5, 2013
Sales and Marketing AstraZeneca, BMS, lipodystrophy

AstraZeneca and partner Bristol-Myers Squibb have been granted a priority review for their rare disease drug metreleptin. The medicine is …

Sanofi admits $285m failure

June 4, 2013
Research and Development, Sales and Marketing Sanofi, its benzamide iniparib, otamixaban

Sanofi has consigned two investigational drugs to the corporate dustbin, preferring a $285 million dent in its coffers to continuing …

USP image

USP delays guidance on elemental impurities

June 4, 2013
Manufacturing and Production Q3D, USP

The US Pharmacopeial Convention (USP) has agreed to postpone the deadline for implementing two new chapters on elemental impurities in …

Boehringer image

NSCLC lift for Boehringer

June 4, 2013
Research and Development, Sales and Marketing Boehringer, NSCLC

Boehringer’s pipeline has been boosted with the news that its investigational oral triple angiokinase inhibitor nintedanib plus chemotherapy, extends the …

Complications combat image

Boehringer and Lilly launch diabetes game

June 4, 2013
Medical Communications Boehringer Ingelheim, combat, lilly

Boehringer Ingelheim and Eli Lilly have launched an educational digital game for type 2 diabetes called Complications Combat. The game …

brent_lang

Vocera appoints president and chief executive

June 4, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brent Lang, Vocera

Healthcare comms firm Vocera Communications has announced Brent Lang’s appointment as president and chief executive officer to the firm and …

Howe and Willetts image

UK government cautious on trial transparency

June 4, 2013
Research and Development, Sales and Marketing Goldacre, UK, alltrials, transparency

Two ministers with responsibility for life sciences in the UK struck a cautious note over clinical trial transparency at an …

SHL attends the 2013 Japan PDA

June 4, 2013
Manufacturing and Production auto injectors, autoinjector, autoinjectors, japan pda. shl pda

SHL once again had the honor of being invited to participate and speak at the PDA Japan 2013 (日本PDA製薬学会), which …

Promising signs for Novartis’ lung cancer drug

June 4, 2013
Sales and Marketing ALK+, ASCO, LDK378, NSCLC, Novartis

Targeted lung cancer treatment LDK378 has been shown to help patients with the ALK+ gene mutation in a phase I trial.Novartis’ drug …

fda image

FDA issues draft guidance on contract manufacturing

June 3, 2013
Manufacturing and Production FDA, GMP, Taylor

The US Food and Drug Administration FDA has published draft guidance on quality agreements between pharma companies and contract manufacturers. …

Sinovac appoints chief financial officer

June 3, 2013
Manufacturing and Production, Research and Development, Sales and Marketing China, Sinovac

China-based biopharma products provider Sinovac Biotech has appointed vice president Nan Wang to be its chief financial officer. Previous CFO …

Europe image

Europe votes yes on greater trial transparency

June 3, 2013
Research and Development, Sales and Marketing Europe, Goldacre, alltrials, transparency

Europe has taken one step closer to increasing clinical trial transparency on the continent after MEPs voted yes on new …

Roche image

Lilly and Roche back US research institute

May 31, 2013
Research and Development, Sales and Marketing Roche, lilly, notre dame, research

Eli Lilly and Roche Diagnostics are among the key backers of a $360 million US life sciences research facility which …

Eylea image

NICE green light for Eylea

May 31, 2013
Sales and Marketing Bayer, NICE, Regeneron

NICE has recommended Bayer’s injection Eylea as a treatment for neovascular (wet) age-related macular degeneration (AMD) if the manufacturer offers …

Teva image

Fatality as blast rocks Teva manufacturing plant

May 31, 2013
Manufacturing and Production Teva

One man died and more than 30 other people were injured after an explosion hit a manufacturing facility operated by …

AstraZeneca image

AstraZeneca and CRUK partner on drug trial

May 31, 2013
Sales and Marketing AstraZeneca, CRUK

AstraZeneca is partnering with Cancer Research UK to develop a new oncology medicine that targets a number of different cancers. …

ramani

Avillion appoints chief business officer

May 31, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Avillion

Venture capitalist firm Avillion has announced the expansion of its leadership team with the appointment of Ramani Varanasi as chief …

Pfizer, UCB sell plants to smaller drugmakers

May 30, 2013
Manufacturing and Production Pfizer, UCB

This week saw two pharma companies offload US manufacturing facilities to contract manufacturing organisations (CMOs), with Pfizer selling a plant …

The Gateway to Local Adoption Series

Latest content